Phase 3 Lung Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- You have been diagnosed with non-small cell lung cancer (NSCLC) confirmed by a lab test, of any type.
- Your lung cancer has spread to other parts of the body (Stage IV) and cannot be cured with current treatments.
- Your cancer does not have certain specific gene changes (called EGFR mutations, ALK rearrangements, or ROS1 rearrangements) that would make other targeted treatments more appropriate.
- Your cancer does not have any other known gene changes for which there are already approved targeted treatments available locally.
- You are generally well enough to carry out light activity and care for yourself, and your health has not gotten worse in the 2 weeks before the study screening (confirm with trial site).
- Doctors expect you to live for at least 12 weeks.
- You are able to provide a tumor tissue sample for testing before joining the trial.
- You have at least one area of cancer that has not been treated with radiation before and is large enough to be measured accurately on a CT or MRI scan.
- Your organs (such as kidneys and liver) and bone marrow are functioning well enough (confirm with trial site for specific values).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- You have a serious or uncontrolled illness that the study doctor believes would make it unsafe or difficult for you to participate.
- You have previously had an organ transplant.
- You have an autoimmune or inflammatory condition (such as lupus or rheumatoid arthritis) that currently requires or has required long-term treatment with steroids or other medicines that suppress the immune system.
- You have had another type of cancer in the past, unless it was successfully treated at least 2 years ago with a low chance of coming back.
- Your lung cancer includes certain rare cell types called small cell or neuroendocrine components.
- You have cancer that has spread to the brain, unless it is stable, causing no symptoms, and you have not needed steroids or anti-seizure medicines for at least 4 weeks.
- You have an active condition that weakens your immune system, or an active infection.
- You currently have an active tuberculosis (TB) infection.
- You have already received any treatment aimed at your advanced or metastatic NSCLC.
- You have previously been treated with a therapy targeting a protein called TIGIT, or any other cancer treatment that works by targeting immune-regulating pathways.
- You have previously received treatment with drugs known as anti-PD-1 or anti-PD-L1 medicines (a type of immunotherapy).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Overall Survival (OS); Progression-Free Survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.